Association for Innovation and Biomedical Research on Light and Image
PUBLICATION NAME
A non-randomised, open-label, multicenter phase 4 pilot study on the effect and safety of ILUVIEN® in chronic diabetic macular edema patients considered insufficiently responsive to available therapies (RESPOND).
4C // COIMBRA COORDINATING CENTRE FOR CLINICAL RESEARCH
A non-randomised, open-label, multicenter phase 4 pilot study on the effect and safety of ILUVIEN® in chronic diabetic macular edema patients considered insufficiently responsive to available therapies (RESPOND).
Figueira J, Henriques J, Amaro M, Rosas V, Alves D, Cunha-Vaz J
Ophthalmic Reserch DOI: 10.1159/000455235
2017
